DEMAREE JOHN 4
4 · Karyopharm Therapeutics Inc. · Filed Mar 17, 2020
Insider Transaction Report
Form 4
DEMAREE JOHN
Chief Commercial Officer
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2020-03-16+151,200→ 151,200 totalExercise: $16.50Exp: 2030-03-15→ Common Stock (151,200 underlying)
Footnotes (1)
- [F1]This option was granted on March 16, 2020. The shares underlying this option vest as to 25% of the shares on March 16, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.